Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Fresenius Se & Company Kg ADR (FSNUY)

Fresenius Se & Company Kg ADR (FSNUY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 31,231,460
  • Shares Outstanding, K 2,234,010
  • Annual Sales, $ 23,625 M
  • Annual Income, $ 509,670 K
  • EBIT $ 2,439 M
  • EBITDA $ 3,742 M
  • 60-Month Beta 0.76
  • Price/Sales 1.28
  • Price/Cash Flow 11.10
  • Price/Book 1.46
  • Price/Earnings ttm 16.28
  • Earnings Per Share ttm 0.88
  • Most Recent Earnings $0.23 on 11/05/25
  • Next Earnings Date 02/25/26
  • Annual Dividend & Yield 0.19 (1.34%)
  • Most Recent Dividend 0.188 on 05/27/25
  • Sector Medical
  • INDUSTRY GROUPING Medical - Outpatient & Hm Care

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.18
  • Growth Rate Est. (year over year) +554,900.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.5950 +2.83%
on 12/09/25
14.8600 -5.92%
on 12/10/25
+0.3650 (+2.68%)
since 12/02/25
3-Month
13.2800 +5.27%
on 11/06/25
33.9300 -58.80%
on 10/31/25
+0.1600 (+1.16%)
since 10/02/25
52-Week
8.6300 +61.99%
on 01/03/25
33.9300 -58.80%
on 10/31/25
+5.3600 (+62.18%)
since 01/02/25

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Fresenius SE & Co is a health care company. It offers products and services for dialysis, hospitals and outpatient treatment. The company's business segment consists of Fresenius Medical Care is engaged in treating with chronic kidney failure; Fresenius Helios is a hospital operator; Fresenius Kabi supplies...

See More

Key Turning Points

3rd Resistance Point 14.5133
2nd Resistance Point 14.3667
1st Resistance Point 14.1733
Last Price 13.9800
1st Support Level 13.8333
2nd Support Level 13.6867
3rd Support Level 13.4933

See More

52-Week High 33.9300
Fibonacci 61.8% 24.2654
Fibonacci 50% 21.2800
Fibonacci 38.2% 18.2946
Last Price 13.9800
52-Week Low 8.6300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar